Literature DB >> 24056648

Evaluation of a new tuberculosis-related interferon gamma release assay for tuberculosis infection diagnosis in Huzhou, eastern China.

Fuchu Qian1, Weihong Wang, Zhihong Qiu, Yiqun Shen, Jiangfang He, Dongli Li, Jing Zhong, Licheng Dai.   

Abstract

OBJECTIVE: To compare the performance of a new tuberculosis-related interferon gamma release assay (TB-IGRA) with that of QuantiFERON-TB Gold In-Tube (QFT-GIT) for TB infection diagnosis in China.
MATERIALS AND METHODS: A total of 458 active TB patients and 378 healthy individuals were enrolled. Among the 458 active TB patients, 395 had pulmonary TB and 63 had extra-pulmonary TB. The blood samples were collected from the active TB patients and health controls; then TB-IGRA and QFT-GIT were used to detect interferon gamma (IFN-γ) levels.
RESULTS: The sensitivity, specificity, positive predictive value, and negative predictive value in TB infection diagnosis for active TB by the TB-IGRA were 83.4%, 94.2%, 94.5%, and 82.4%, respectively. For QFT-GIT, the sensitivity, specificity, positive predictive value, and negative predictive value in TB infection diagnosis for active TB were 81.4%, 97.1%, 97.1%, and 81.2%, respectively.
CONCLUSIONS: TB-IGRA had a high sensitivity and specificity for TB infection; it could be comparable with the QFT-GIT assay. It might be a powerful assisting tool for TB infection diagnosis in the Chinese clinical setting.

Entities:  

Mesh:

Year:  2013        PMID: 24056648     DOI: 10.4103/0377-4929.118694

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  6 in total

1.  Evaluation of the characteristics of the enzyme-linked immunospot assay for diagnosis of active tuberculosis in China.

Authors:  Linchuan Wang; Yan Yu; Wei Chen; Jin Feng; Jinyuan Wang; Heping Zhao; Lietin Ma; Bo Yang; Yanfen Ma; Pei Dang
Journal:  Clin Vaccine Immunol       Date:  2015-03-04

2.  Diagnostic accuracy of interferon-gamma release assays for diagnosis of smear-negative pulmonary tuberculosis: a systematic review and meta-analysis.

Authors:  Tananchai Petnak; Dararat Eksombatchai; Supavit Chesdachai; Ploypin Lertjitbanjong; Pahnwat Taweesedt; Angsupat Pornchai; Charat Thongprayoon; Larry J Prokop; Zhen Wang
Journal:  BMC Pulm Med       Date:  2022-06-06       Impact factor: 3.320

3.  Diagnostic Utility of QuantiFERON-TB Gold (QFT-G) in Active Pulmonary Tuberculosis.

Authors:  Ahmed Anwar; Al-Jahdali Hamdan; Baharoon Salim; Ali Yosra; Mohamed Hani; Al-Harbi Abdullah
Journal:  J Glob Infect Dis       Date:  2015 Jul-Sep

4.  An alert of Mycobacterium tuberculosis infection of rhesus macaques in a wild zoo in China.

Authors:  Wenping Gong; Yourong Yang; Yi Luo; Ning Li; Xuejuan Bai; Yinping Liu; Junxian Zhang; Ming Chen; Chenglin Zhang; Xueqiong Wu
Journal:  Exp Anim       Date:  2017-06-29

5.  Costs and Consequences of Using Interferon-γ Release Assays for the Diagnosis of Active Tuberculosis in India.

Authors:  Kristen M Little; Madhukar Pai; David W Dowdy
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

6.  Relation between BCG vaccine scar and an interferon-gamma release assay in immigrant children with "positive" tuberculin skin test (≥10 mm).

Authors:  Margret Johansson Gudjónsdóttir; Karsten Kötz; Ruth Stangebye Nielsen; Philip Wilmar; Sofia Olausson; Daniel Wallmyr; Birger Trollfors
Journal:  BMC Infect Dis       Date:  2016-10-06       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.